Zenicor Medical Systems Stock Current Valuation
| ZENI Stock | SEK 1.77 0.00 0.00% |
Valuation analysis of Zenicor Medical Systems helps investors to measure Zenicor Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Zenicor Medical's price fluctuation is dangerous at this time. Calculation of the real value of Zenicor Medical Systems is based on 3 months time horizon. Increasing Zenicor Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Zenicor Medical's intrinsic value may or may not be the same as its current market price of 1.77, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.77 | Real 1.53 | Hype 1.77 |
The intrinsic value of Zenicor Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Zenicor Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Zenicor Medical Systems helps investors to forecast how Zenicor stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zenicor Medical more accurately as focusing exclusively on Zenicor Medical's fundamentals will not take into account other important factors: Zenicor Medical Systems Company Current Valuation Analysis
Zenicor Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Zenicor Medical Systems has a Current Valuation of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Current Valuation (which currently averages 0.0) industry. This indicator is about the same for all Sweden stocks average (which is currently at 0.0).
Zenicor Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zenicor Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zenicor Medical could also be used in its relative valuation, which is a method of valuing Zenicor Medical by comparing valuation metrics of similar companies.Zenicor Medical is currently under evaluation in current valuation category among its peers.
Zenicor Fundamentals
| EBITDA | (5.84 M) | |||
| Total Asset | 10 M | |||
| Retained Earnings | 7 M | |||
| Current Asset | 10 M | |||
| Current Liabilities | 2 M |
About Zenicor Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zenicor Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zenicor Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zenicor Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Zenicor Stock Analysis
When running Zenicor Medical's price analysis, check to measure Zenicor Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zenicor Medical is operating at the current time. Most of Zenicor Medical's value examination focuses on studying past and present price action to predict the probability of Zenicor Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zenicor Medical's price. Additionally, you may evaluate how the addition of Zenicor Medical to your portfolios can decrease your overall portfolio volatility.